Polysilicone base for scar treatment
A polysilicone base for medical and cosmetic compositions includes a dimethicone fluid, a volatile cyclosiloxane, a silicone elastomer, and nanoparticulate silica. The polysilicone base may also include one or more therapeutic agents for reducing the formation and appearance of scar tissue at the site of a wound. The polysilicone base is spreadable, but does not run off of the wound site. The polysilicone base is phase-stable, in that it does not separate into phases.
1. A polysilicone base for medical and cosmetic compositions, comprising:
a first dimethicone fluid having a viscosity of about 100 cSt;
a second dimethicone fluid having a viscosity of about 1,000 cSt;
a third dimethicone fluid having a viscosity of about 60,000 cSt;
volatile cyclopentasiloxane fluid;
a stearoxymethicone/dimethicone copolymer; and
a nanoparticulate silica, wherein said polysilicone base is phase stable.
2. The polysilicone base of claim 1 , wherein said stearoxymethicone/dimethicone copolymer is present in said polysilicone base in an amount in the range of from about 23% to about 35% by weight.
3. The polysilicone base of claim 1 , wherein said nanoparticulate silica is present in said polysilicone base in an amount in the range of from about 0.4% to about 0.8% by weight.
4. The polysilicone base of claim 1 , wherein said polysilicone base has a viscosity in the range of 2,200,000 cSt to 3,200,000 cSt.
5. The polysilicone base of claim 1 , wherein said polysilicone base spreads easily over the skin.
6. The polysilicone base of claim 1 , wherein at least said first and second dimethicones and said volatile cyclopentasiloxane are of types recognized in the medical arts as medical grade materials.
7. The polysilicone base of claim 1 , further comprising at leas one therapeutic agent for reducing the formation and/or appearance of scar tissue at a site of a wound.